tradingkey.logo
tradingkey.logo
Search

Kymera Therapeutics Inc

KYMR
Add to Watchlist
103.400USD
-3.610-3.37%
Close 07-31 16:00ETQuotes delayed by 15 min
8.51BMarket Cap
LossP/E TTM

KYMR Financials

See Kymera Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Kymera Therapeutics Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/-0.72
Revenue / Forecast
--/30.44M
Period
FY2025 Earnings
Revenue(YoY)
39.21M
-16.70%
EPS(YoY)
-3.69
-23.53%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
13.25%-0.71
-9.53%-0.97
-14.67%-0.94
-65.42%-0.95
-19.26%-0.82
-259.40%-0.88
9.29%-0.82
13.45%-0.58
2.46%-0.69
59.21%-0.25
---0.90
---0.67
---0.70
---0.60
---2.28
----
----
----
----
----
Revenue
55.50%34.37M
-61.18%2.87M
-26.12%2.76M
-55.26%11.48M
114.83%22.10M
-84.56%7.39M
-20.88%3.74M
55.33%25.65M
8.67%10.29M
196.70%47.88M
-50.50%4.73M
43.42%16.51M
-1.62%9.47M
5.66%16.14M
-53.03%9.55M
-37.83%11.51M
-48.55%9.62M
19.48%15.28M
39.93%20.34M
--18.52M
Net Profit
-5.57%-69.23M
-22.94%-86.98M
-31.51%-82.17M
-82.15%-76.61M
-35.06%-65.58M
-392.43%-70.75M
-18.20%-62.49M
-8.41%-42.06M
-18.64%-48.56M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.80M
-11.57%-40.93M
-2.85%-34.87M
-50.45%-43.00M
-63.25%-40.26M
-180.57%-36.68M
-167.24%-33.90M
-257.90%-28.58M
---24.66M
Net Margin
32.11%-201.47%
-216.73%-3030.70%
-77.99%-2973.05%
-307.11%-667.60%
37.13%-296.75%
-3089.06%-956.88%
-49.38%-1670.33%
30.21%-163.98%
-9.17%-472.02%
86.11%-30.01%
---1118.17%
---234.96%
---432.37%
---216.03%
---390.86%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
-54.74%0.17%
-50.88%0.19%
12.37%0.34%
55.23%0.36%
43.21%0.38%
-14.51%0.38%
-0.31%0.30%
-31.60%0.23%
-30.48%0.26%
1.76%0.45%
--0.30%
--0.34%
--0.38%
--0.44%
--0.28%
----
----
----
----
----
Revenue
55.50%34.37M
-61.18%2.87M
-26.12%2.76M
-55.26%11.48M
114.83%22.10M
-84.56%7.39M
-20.88%3.74M
55.33%25.65M
8.67%10.29M
196.70%47.88M
-50.50%4.73M
43.42%16.51M
-1.62%9.47M
5.66%16.14M
-53.03%9.55M
-37.83%11.51M
-48.55%9.62M
19.48%15.28M
39.93%20.34M
--18.52M
Operating profit
-13.07%-84.15M
-21.23%-97.90M
-22.94%-88.67M
-66.04%-84.56M
-40.68%-74.43M
-318.16%-80.75M
-25.41%-72.12M
-17.38%-50.92M
-16.72%-52.91M
50.01%-19.31M
-28.13%-57.51M
-6.30%-43.38M
-22.72%-45.33M
-13.64%-38.63M
-56.73%-44.88M
-65.02%-40.81M
-180.45%-36.93M
-165.95%-33.99M
-254.29%-28.64M
---24.73M
Net Profit
-5.57%-69.23M
-22.94%-86.98M
-31.51%-82.17M
-82.15%-76.61M
-35.06%-65.58M
-392.43%-70.75M
-18.20%-62.49M
-8.41%-42.06M
-18.64%-48.56M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.80M
-11.57%-40.93M
-2.85%-34.87M
-50.45%-43.00M
-63.25%-40.26M
-180.57%-36.68M
-167.24%-33.90M
-257.90%-28.58M
---24.66M
Current assets
35.23%677.43M
70.74%871.21M
-7.11%528.30M
38.62%728.33M
-6.76%500.95M
25.89%510.27M
51.38%568.72M
36.33%525.41M
30.54%537.25M
-3.36%405.32M
-23.95%375.69M
-4.31%385.40M
-4.60%411.55M
-7.06%419.42M
-9.14%494.02M
10.41%402.77M
26.58%431.38M
49.26%451.27M
82.85%543.73M
130.45%364.81M
Total current liabilities
6.19%62.64M
22.79%83.21M
7.58%71.58M
40.87%87.54M
5.08%58.99M
-20.92%67.77M
5.33%66.53M
13.81%62.14M
-9.36%56.14M
20.11%85.69M
-30.68%63.17M
-37.60%54.60M
-29.89%61.93M
-22.91%71.34M
-3.57%91.12M
-19.49%87.50M
-19.79%88.34M
-16.34%92.54M
-11.92%94.49M
154.65%108.69M
Total assets
81.75%1.67B
78.20%1.74B
6.49%1.10B
36.93%1.13B
5.77%918.31M
69.87%978.03M
87.34%1.03B
41.94%826.02M
41.43%868.25M
-4.54%575.76M
-13.48%552.38M
11.18%581.95M
9.03%613.90M
-0.46%603.13M
-0.62%638.47M
20.50%523.42M
21.20%563.06M
24.37%605.90M
26.63%642.45M
139.85%434.39M
Total liabilities
-2.04%129.38M
14.56%163.15M
9.78%155.79M
13.11%159.59M
-15.90%132.08M
-21.22%142.42M
-9.52%141.91M
-3.70%141.10M
3.39%157.05M
60.01%180.79M
24.89%156.84M
16.77%146.52M
13.07%151.90M
-22.76%112.98M
-21.17%125.59M
-28.82%125.47M
-29.04%134.34M
-28.05%146.27M
-25.09%159.32M
128.74%176.28M
Total equity
95.82%1.54B
89.04%1.58B
5.97%946.26M
41.84%971.48M
10.55%786.23M
111.56%835.62M
125.75%892.93M
57.30%684.92M
53.94%711.20M
-19.42%394.97M
-22.88%395.54M
9.42%435.43M
7.76%462.00M
6.64%490.15M
6.16%512.88M
54.18%397.95M
55.76%428.72M
61.91%459.64M
63.95%483.13M
148.07%258.10M
Net operating income
-12.24%-88.84M
-8.03%-66.75M
45.99%-27.11M
-39.47%-59.88M
-99.92%-79.15M
-867.98%-61.78M
-58.59%-50.19M
-21.78%-42.94M
9.95%-39.59M
120.35%8.04M
7.65%-31.65M
9.57%-35.26M
-9.12%-43.97M
-3.09%-39.54M
8.03%-34.27M
-27.77%-38.98M
-76.55%-40.30M
-91.11%-38.35M
-128.30%-37.26M
---30.51M
Net investment
-393.82%-142.84M
-675.19%-394.40M
-49.23%-235.30M
283.72%60.02M
114.70%48.62M
261.80%68.57M
-360.58%-157.68M
-56.35%15.64M
-1444.81%-330.61M
138.16%18.95M
261.44%60.51M
-56.19%35.84M
-4.95%24.58M
26.98%-49.67M
72.61%-37.48M
34.72%81.80M
-41.65%25.86M
-1604.74%-68.02M
59.06%-136.86M
--60.72M
Net financing
7174.81%18.77M
25405.21%705.22M
-84.25%39.51M
17302.69%245.73M
-99.93%258.00K
42.97%2.77M
121904.85%250.92M
8.20%1.41M
30422.52%353.76M
-0.97%1.93M
-100.14%-206.00K
258.52%1.30M
526.49%1.16M
-4.92%1.95M
-38.83%150.50M
-77.14%364.00K
-68.91%185.00K
660.74%2.05M
25.35%246.04M
--1.59M

FAQs

What is the total revenue of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its total revenue reached 39.21M, with a year-on-year change of 47.07M.

What are the current assets of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its current assets were 871.21M, with a year-on-year change of 70.74.

What are the total assets of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its total assets of Kymera Therapeutics Inc were 1.74B, with a year-on-year change of 78.20.

What are the total liabilities of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its total liabilities of Kymera Therapeutics Inc were 163.15M, with a year-on-year change of 14.56.

What is the total equity of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its total equity of Kymera Therapeutics Inc was 1.58B, with a year-on-year change of 89.04.

What is the net operating income of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its net operating income of Kymera Therapeutics Inc was -345.54M, with a year-on-year change of -34.60.

What is the net investment of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its net investment of Kymera Therapeutics Inc was -521.06M, with a year-on-year change of -28.95.

What is the net financing of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its net financing of Kymera Therapeutics Inc was 990.71M, with a year-on-year change of 62.72.

What is the Earnings Per Share (EPS) of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.69, with a year-on-year change of -23.53.

What is the net income of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its net income was -311.35M, with a year-on-year change of -39.08.

What is the net margin of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its net profit margin was -794.04, with a year-on-year change of -66.97.

What is the debt-to-asset ratio of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.19, with a year-on-year change of -50.88.

What is the Return on Equity (ROE) of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -25.78, with a year-on-year change of 29.14.

What is the Return on Assets (ROA) of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -22.89, with a year-on-year change of 20.57.

What is the operating profit of Kymera Therapeutics Inc?

According to Kymera Therapeutics Inc's FY2025 earnings report, its operating profit was -345.54M, with a year-on-year change of -34.60.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.